论文部分内容阅读
Ｏｎｄａｎｓｅｔｒｏｎ－－一种新研制的止吐药枢复宁（Ｏｎｄａｎｓｅｔｒｏｎ，ＺｏｆｒｅｎＺｏｆｒａｎ）是一种新型的止吐药，为５－ＨＴ３受体拮抗剂。英国ＧＬａｘｏ公司于１９９０年首次上市，１９９１年１月美国ＦＤＡ批准于２月投入市场。临床应用证实对由抗肿...
Ondansetron, a new antiemetic drug developed by Zofren Zofran, a new antiemetic drug, is a 5-HT3 receptor antagonist. British GLaxo company first listed in 1990, January 1991 the United States FDA approved in February to market. Clinical application confirmed by the anti-swollen ...